Cargando…
Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819034/ https://www.ncbi.nlm.nih.gov/pubmed/31503058 http://dx.doi.org/10.1097/CM9.0000000000000441 |
| _version_ | 1783463664523673600 |
|---|---|
| author | Liu, Shuang Li, Chen Tang, Ming-Wei Xu, Wen-Shuai Chen, Ke-Qi Sui, Xin Tian, Xin-Lun Xu, Kai-Feng |
| author_facet | Liu, Shuang Li, Chen Tang, Ming-Wei Xu, Wen-Shuai Chen, Ke-Qi Sui, Xin Tian, Xin-Lun Xu, Kai-Feng |
| author_sort | Liu, Shuang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6819034 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68190342019-11-18 Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome Liu, Shuang Li, Chen Tang, Ming-Wei Xu, Wen-Shuai Chen, Ke-Qi Sui, Xin Tian, Xin-Lun Xu, Kai-Feng Chin Med J (Engl) Correspondence Wolters Kluwer Health 2019-10-05 2019-09-23 /pmc/articles/PMC6819034/ /pubmed/31503058 http://dx.doi.org/10.1097/CM9.0000000000000441 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| spellingShingle | Correspondence Liu, Shuang Li, Chen Tang, Ming-Wei Xu, Wen-Shuai Chen, Ke-Qi Sui, Xin Tian, Xin-Lun Xu, Kai-Feng Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome |
| title | Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome |
| title_full | Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome |
| title_fullStr | Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome |
| title_full_unstemmed | Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome |
| title_short | Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome |
| title_sort | improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819034/ https://www.ncbi.nlm.nih.gov/pubmed/31503058 http://dx.doi.org/10.1097/CM9.0000000000000441 |
| work_keys_str_mv | AT liushuang improvementoflymphangioleiomyomatosisfollowingsuccessfultofacitinibtreatmentforrefractorysynovitisacnepustulosishyperostosisandosteitissyndrome AT lichen improvementoflymphangioleiomyomatosisfollowingsuccessfultofacitinibtreatmentforrefractorysynovitisacnepustulosishyperostosisandosteitissyndrome AT tangmingwei improvementoflymphangioleiomyomatosisfollowingsuccessfultofacitinibtreatmentforrefractorysynovitisacnepustulosishyperostosisandosteitissyndrome AT xuwenshuai improvementoflymphangioleiomyomatosisfollowingsuccessfultofacitinibtreatmentforrefractorysynovitisacnepustulosishyperostosisandosteitissyndrome AT chenkeqi improvementoflymphangioleiomyomatosisfollowingsuccessfultofacitinibtreatmentforrefractorysynovitisacnepustulosishyperostosisandosteitissyndrome AT suixin improvementoflymphangioleiomyomatosisfollowingsuccessfultofacitinibtreatmentforrefractorysynovitisacnepustulosishyperostosisandosteitissyndrome AT tianxinlun improvementoflymphangioleiomyomatosisfollowingsuccessfultofacitinibtreatmentforrefractorysynovitisacnepustulosishyperostosisandosteitissyndrome AT xukaifeng improvementoflymphangioleiomyomatosisfollowingsuccessfultofacitinibtreatmentforrefractorysynovitisacnepustulosishyperostosisandosteitissyndrome |